KOR

e-Article

A Swedish nationwide pharmaco-epidemiological study of the long-term safety and effectiveness of alemtuzumab (IMSE 3)
Document Type
ConferencePaper
Source
MULTIPLE SCLEROSIS JOURNAL. 24:706-707
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1352-4585